Preoperative ROX Index and Postoperative Hypoxemia in Bariatric Surgery

ConditionHypoxemia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorIstinye University

About this trial

This prospective observational study evaluates whether the preoperative ROX index can predict early postoperative hypoxemia in patients undergoing bariatric surgery. Preoperative ROX measurements, along with ARISCAT and STOP-Bang scores, will be assessed for their association with hypoxemia occurring within the first 12 postoperative hours.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18-65 years

Scheduled for elective bariatric surgery (laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass)

Body mass index (BMI) ≥ 35 kg/m²

ASA physical status I-III

Disqualifiers

Acute respiratory failure, pneumonia, or active pulmonary infection

Receiving oxygen therapy or respiratory support (nasal cannula, CPAP, BiPAP, or high-flow oxygen) preoperatively

Preoperative SpO₂ < 88% on room air

Significant cardiac arrhythmia, severe heart failure (NYHA class III-IV), or hemodynamic instability

Trial population

The study population consists of adult patients scheduled for elective bariatric surgery, including laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. All participants are obese (BMI ≥ 35 kg/m²) and evaluated preoperatively in the anesthesia clinic prior to surgery.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Preoperative ROX Index Assessment

    Other intervention

    Participants will undergo a preoperative assessment including measurement of the ROX index (SpO₂/FiO₂ divided by respiratory rate) before bariatric surgery. No treatment or study-related intervention will be applied; all perioperative care will follow routine clinical practice.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Early Postoperative Hypoxemia

Hypoxemia defined as SpO₂ \< 92% or new oxygen requirement within the first postoperative hours.

Time frame
Postoperative 0-12 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: